Temozolomide combined with radiotherapy is the main treatment for glioma after surgery, in this study, we experimentally demonstrated that TCID, an inhibitor of UCHL3, has a specific synergistic effect on treatment, and the combination of the two can inhibit the growth of tumour to a greater extent. Here, UCHL3 is linked to central nervous system cancer.